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Abstract
Objective –—Unreliable antibodies often hinder the accurate detection of an endogenous 
protein, and this is particularly true for the cardiac and smooth muscle cofactor, Myocardin 
(MYOCD). Accordingly, the mouse Myocd locus was targeted with two independent epitope tags 
for the unambiguous expression, localization, and activity of MYOCD protein.
Approach and Results –—3-component CRISPR was used to engineer a carboxyl-terminal 
3xFLAG or 3xHA epitope tag in mouse embryos. Western blotting with antibodies to each tag 
revealed a protein product of ~150 kDa, a size considerably larger than that reported in virtually 
all publications. MYOCD protein was most abundant in some adult smooth muscle-containing 
tissues with surprisingly low-level expression in heart. Both alleles of Myocd are active in aorta 
since a two-fold increase in protein was seen in mice homozygous versus heterozygous for FLAG-
tagged Myocd. ChIP-qPCR studies provide proof-of-principle data demonstrating the utility of this 
mouse line in conducting genome-wide ChIP-seq studies to ascertain the full complement of 
MYOCD-dependent target genes in vivo. Although FLAG-tagged MYOCD protein was 
undetectable in sections of adult mouse tissues, low-passaged VSMC exhibited expected nuclear 
localization.
Conclusion –—This report validates new mouse models for analyzing MYOCD protein 
expression, localization, and binding activity in vivo and highlights the need for rigorous 
authentication of antibodies in biomedical research.
To whom correspondence should be addressed: Joseph M. Miano, PhD, Aab Cardiovascular Research Institute, University of 
Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Rochester, NY 14624, Phone: 585-276-7703, Fax: 585-276-9830, 
j.m.miano@rochester.edu. 
Disclosures
None.
HHS Public Access
Author manuscript
Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2019 September 01.
Published in final edited form as:
Arterioscler Thromb Vasc Biol. 2018 September ; 38(9): 2184–2190. doi:10.1161/ATVBAHA.
118.311171.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Keywords
CRISPR; Myocardin; smooth muscle; antibody
Introduction
The trustworthy detection, localization, and interactive association of a protein are essential 
to understanding cellular processes under normal and pathological conditions. Yet, biology 
is plagued by fallacious antibodies,1 particularly those directed against transcription factors.2 
Accordingly, antibodies to a variety of epitope tags have been developed to circumvent the 
difficulties often encountered with monoclonal or polyclonal antibodies.3 Epitope tagging is 
commonplace in labs using plasmids to study ectopic protein expression. Far fewer 
examples exist with the tagging of endogenous protein-coding gene loci in mice,4–6 likely 
due to the labor-intensive approach of traditional gene targeting. However, the CRISPR-
Cas9 genome editing system7–9 has revolutionized the production of novel mouse strains, 
including those carrying epitope tags.1011 Here, we present the accurate expression, 
localization, and binding activity of epitope tagged Myocardin (MYOCD), a serum response 
factor (SRF) cofactor12 that powerfully drives the program of vascular smooth muscle cell 
(VSMC) differentiation.13–16
Material and Methods
3-Component CRISPR editing of the Myocd locus
For the Myocd3xFLAG mouse, sgRNA of sequence ACAGCAGUGGUAAACACCCG 
(synthesized in vitro as described17) was tested for activity in a split reporter assay18 (see 
Supplemental Figure IIB) and injected (50 ng/μl) with Cas9 mRNA (100 ng/μl, TriLink 
Biotechnologies) and a symmetric, single-strand oligonucleotide containing the 3xFLAG 
sequence (100 ng/μl, Ultrapure PAGE-purified, Integrated DNA Technologies) into the 
pronucleus of C57BL/6J zygotes. The single-strand oligonucleotide was of the same strand 
as the sgRNA so as to prevent hybridization of the two in the embryo. For the Myocd3xHA 
mouse, synthetic sgRNA (same as above) and CAS9 protein (both from Synthego) were 
validated for DNA cleavage in an in vitro tube assay as described by the manufacturer. 
CAS9 protein and sgRNA were mixed (3 pmol each) as a ribonucleoprotein complex and 
then combined with a 249 single-strand Megamer oligonucleotide (100 ng/μl, Integrated 
DNA Technologies) prior to cytoplasmic injection. Viable two-cell stage embryos were 
transferred to pseudo-pregnant C57BL/6J females.
Local Institutional Animal Care and Use Committees approved all mouse studies.
Mouse pup genotyping, off-targeting, and breeding
One-week old founder pups were toe-clipped or ear-punched and tissue was digested 
overnight at 55°C in lysis buffer (50 mM KCl, 10 mM Tris-HCL [pH 9], 0.1% Triton X-100, 
and 0.2 mg/ml proteinase K) on an interval mixer. The next morning, samples were heated at 
95°C for 10 minutes to inactivate the proteinase K and spun down at 15,000xg for 10 
minutes. Each sample of DNA (1μl) was mixed with 12 μl nuclease-free water, 10 μl 
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AccuStart II Supermix (Quantabio), and 1 μl each of forward and reverse primers (see Table 
I in the online-only Data Supplement) flanking the double-strand break (see Figure II in the 
online-only Data Supplement). PCR conditions were 1 cycle of 95°C for 3 minutes followed 
by 30 cycles of 95°C (30 sec), 58°C (45 sec), and 72°C (1 minute) and a final 7-minute cycle 
at 72°C.
Off-targeting was assessed initially with CCTop,19 Cas-OFFinder,20 and the MIT CRISPR 
website21 and later with the CRISPOR tool.22 No predicted off-targets were found within 
two megabases of the on-target double-strand break. We selected the top nine distal off-
target sites based on an aggregate analysis of each prediction program. PCR primers 
flanking each predicted off-target site were synthesized (Integrated DNA Technologies) and 
used to amplify genomic DNA from founder mice as above only the number of PCR cycles 
was limited to 28. Each primer pair contained linker sequences positioned at the 5’ end of 
the template-specific primer sequence necessary for next generation sequencing; the forward 
primers contained the linker sequence, ACACTGACGACATGGTTCTACA and the reverse 
primers contained the linker sequence, TACGGTAGCAGAGACTTGGTCT. Following the 
initial 28-cycle PCR reaction, the samples were verified on an agarose gel and 
approximately equal amounts were subjected to a second PCR reaction (8 cycles only) using 
primers containing Illumina adaptor sequence, 10 bp sample-specific barcodes, and the 
original linker sequences. Amplified sequences were then submitted to the Genomics Core 
for next generation sequencing on an Illumina HiSeq 2500 platform. This setup allowed for 
all nine amplicons to be sequenced in one lane of the sequencer. Raw sequence reads were 
analyzed for indels with CRISPResso.23
Positive founder mice derived from CRISPR-Cas9 genome editing are mosaic.11, 24 We 
therefore backcrossed each positive founder to C57BL/6J mice for Sanger sequencing to 
confirm germline transmission of each epitope tag. Sanger sequencing of F1 mice confirmed 
germline transmission of the correct allele as well as sequence fidelity in and around the 
edited region. Myocd3xFLAG was successfully bred through the germline (in two founders) 
and data were similar in both lines. We confirmed one mosaic founder carrying the 
Myocd3xHA tag, but the line was lost because of dystocia of the pregnant founder. We 
nevertheless isolated tissues for Western (Figure 1B) and limited immunofluorescence 
microscopy of adult tissues (data not shown). Each of the CRISPR-edited mouse lines is 
listed in the Major Resources Table in the Supplemental Material.
RNA isolation, reverse transcription and real-time qPCR
Total RNAs were isolated using RNeasy Mini Kit (Qiagen, #74104) according to the 
manufacturer’s instructions. Reverse transcription was performed using Bio-Rad iScript 
cDNA synthesis kit (Bio-Rad, #1708891) after RNA quantitation and DNase I treatment. 
Real-time qPCR was performed using iTaq™ Universal SYBR® Green Supermix (Bio-Rad, 
#1725121) with customized primers (see Table I in the online-only Data Supplement).
Western blot
Tissues (from male and female mice, aged 6–10 weeks) were isolated and homogenized in 
200μl of cell lysis buffer (Cell Signaling, #9803). After brief centrifugation, supernatants 
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were transferred to fresh 1.5ml microfuge tubes for protein quantitation with DC protein 
assay kit (Bio-Rad, #5000111). Samples were boiled in LDS sampling buffer (Invitrogen, 
#NP0007) and subjected to electrophoresis in SDS-PAGE gel. Proteins were transferred to a 
membrane (PVDF) for 2 hours in cold room at 80V using a Trans-blot machine (Bio-Rad). 
Membranes were then blocked with 5% non-fat milk in TBS-T for 1 hour and incubated 
with primary antibody for 1 hour at room temperature. After washing, secondary antibodies 
were incubated for 1 hour at room temperature followed by immersion in 
chemiluminescence substrate (Thermo-Fisher, #34080) and exposed to X-ray film. A list of 
antibodies used is provided in the Major Resource Table in the online-only Data 
Supplement.
Chromatin immunoprecipitation
At least 5 mouse aortae were isolated and fixed in 10ml of 4% paraformaldehyde at room 
temperature for 10 minutes. One ml of 1.25M glycine was added to stop crosslinking. 
Aortae were washed twice with 1xPBS and 1ml of ChIP lysis buffer (50 mM Tris-HCl pH 
8.0, 150 mM NaCl, 5 mM EDTA, 0.1% deoxycholate, 1% Triton X-100 and protease 
inhibitor cocktail) was added. Tissues were then pulse-sonicated (intervals of 10 second 
pulse over 2 minutes) and centrifuged at 12,000xg for 10 minutes at 4°C. Supernatants were 
collected and transferred to fresh 1.5ml microfuge tubes. Mouse anti-FLAG antibody 
(Sigma-Aldrich, #F3165) and mouse IgG were added to lysate (~500ul each) respectively 
and incubated for 2 hours at 4°C. 100μl Dynabeads protein G (Thermo-Fisher, #10003D) 
were washed twice with 1xPBS and resuspended in the original volume of ChIP lysis buffer 
for each ChIP reaction. Magnetic beads were mixed with antibody-lysate and incubated for 2 
hours at 4°C. After five washes with ChIP lysis buffer, samples were treated with proteinase 
K (10mg/ml) at 55°C on a thermomixer for 1 hour. DNA was then recovered and purified by 
boiling with Chelex-100 resin (Bio-Rad, #1422822) for downstream assays, (eg, real-time 
qPCR).
Isolation and culture of mouse aortic smooth muscle cells
We followed a previously published protocol for isolating mouse aortic SMC.25 Briefly, for 
each independent experiment, three mouse aortae were isolated and placed into ice cold 
HBSS in a 15-ml conical tubes. Aortae were digested with 3ml of Buffer A (10mg 
collagenase II, 10mg soybean trypsin inhibitor in 10ml HBSS) at 37°C for 20 minutes. 
Aortae were then transferred into clean culture dishes loaded with 10ml Buffer B 
(DMEM/F12 medium with 20%FBS and 1% Pen-Strep, pre-warmed to 37°C). The 
adventitial layer was peeled off using fine forceps and aortae were transferred into another 
clean culture dish with 10ml Buffer B. Each aorta was then cut longitudinally and the 
intimal layer was scraped with angled blunt forceps to remove endothelial cells. Aortae were 
cut with fine scissors into 1–2mm pieces and transferred to one well of a 6-well culture plate 
with 3ml Buffer C (3ml Buffer B plus 67ul elastase [Worthington, #LS002279] at 24.8mg/
ml). Tissues were incubated 15 minutes at 37°C followed by repeat pipetting with cut 1ml 
tips to loosen cells. Cells were incubated another 15 minutes at 37°C and dissociated cells 
were repeat pipetted with uncut 1ml tip 5–6 times. The digestion mixture was transferred to 
a clean 15ml canonical tube and 3ml Buffer A was added to stop digestion. Samples were 
centrifuged at 800× g for 5 minutes at 4°C to pellet cells. Cells were resuspended in 5ml 
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Buffer A and plated in a well of 6-well plate. Isolated mouse smooth muscle cells were 
studied upon reaching 50–70% confluency.
Confocal Microscopy
Mouse aortic smooth muscle cells (MASMC) were cultured on 22×22mm coverslips in 6-
well plates. Cells were fixed with 4% paraformaldehyde for 10 minutes at room temperature. 
Coverslips were rinsed in 1xPBS twice and cells permeabilized with 1× PBS containing 
0.1% Triton X-100 on an ice bath. Cells were blocked with 3% BSA for 20 minutes at room 
temperature and anti-FLAG primary antibody (Sigma-Aldrich, #F1804; 1:100 dilution) was 
applied at room temperature for 40 minutes. Coverslips were rinsed twice with 1xPBS and 
cells incubated with fluorescence-conjugated secondary antibodies (1:200) for 40 minutes at 
room temperature. Cells were then mounted with ProLong™ Gold anti-fade reagent with 
DAPI (Thermo-Fisher, #P36935) and examined with an Olympus IX81 confocal microscope 
using uniform settings for all conditions.
Flow cytometry
Aortae derived from the mTmG/Myh11CreERT2 cross were digested as above and freshly 
dissociated MASMC were resuspended in PBS and submitted to the URMC Flow 
Cytometry Core. Cells were sorted according to the Tomato (610nm) or GFP (510nm) signal 
and quantitated as a percentage of total cells stained for GFP or Tomato.
Transfection assays
Rat aortic smooth muscle cells (A7r5, ATCC® CRL-1444™) were transfected with either 
Myocd siRNA (si-Myocd, Cat# SASI_Rn01_00118674, Sigma-Aldrich) or MISSION® 
siRNA Universal Negative Control (si-Scramble, Cat# SIC001, Sigma-Aldrich). Cells were 
mixed with DharmaFECT1 transfection reagent (Lipofectamine 2000, cat# T2001–02, 
Dharmacon) in a 1:1 ratio followed by incubation at room temperature for 20 minutes. Cell 
mixtures were then added to the wells of cell plates followed by incubation for 48 hours at 
37°C. After incubation, cells were washed twice with ice-cold PBS, scraped, and collected 
in either NP-40 lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 0.5% Nonidet P-40) 
containing EDTA-free complete protease and phosphatase inhibitor (Sigma-Aldrich/Roche) 
for protein estimation or Qiazol buffer for mRNA measurement. For protein measurement, 
20μg samples were run on SDS-PAGE gels, transferred to nitrocellulose membrane, blocked 
with 4% non-fat milk, and subsequently incubated with anti-α-tubulin (TUBA1A; cat# 
sc5286, Santa Cruz), or Myocardin (MYOCD; cat# ab22073, Abcam) followed by 
incubation with secondary antibodies and detection using SuperSignal™ West Pico 
Chemiluminescent Substrate (cat# 34080, ThermoFisher Scientific) on autoradiography 
film. For Myocd mRNA levels total RNA was extracted from aorta and bladder using a 
Qiagen miRNeasy kit (Cat # 217004). Input RNA quality and concentration were measured 
using a Synergy HT Take3 Microplate Reader (BioTek, Winooski, VT) and cDNA was 
prepared using SuperScript IV VILO Master Mix (Cat # 11756500, Invitrogen). QPCR was 
performed in triplicate using TaqMan™ Fast Advanced Master Mix (Cat# 44–445-57) in an 
Mx3000p Real-Time PCR System (Stratagene, Santa Clara, CA). The primers for Myocd 
(Assay ID # Rn01786178), were purchased from ThermoFisher Scientific/TaqMan. Results 
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of mRNA expression were normalized to internal control Gapdh, and relative mRNA 
expression was determined using the ΔΔCt method.
NanoLC-MS/MS
Rat aorta, urinary bladder, and A7r5 cells were homogenized and lysed in lysis buffer (50 
mM Tris-HCl [pH 7.4], 150 mM NaCl, 0.5% Nonidet P-40) containing EDTA-free complete 
protease and phosphatase inhibitor (Sigma-Aldrich/Roche). Protein levels were measured 
using Bradford assays (Bio-Rad), after which 30 μg samples were run on SDS-PAGE gels 
followed by fixing the gel (50% methanol and 10% acetic acid) for 40 minutes at room 
temperature and washing for 1 hour. Bands corresponding to 100 kDa were cut and 
subjected to mass spectrometry analysis. The proteins were eluted and analyzed using liquid 
chromatography-tandem mass spectrometry (LC-MS/MS; Applied Biomics, Hayward, CA). 
NanoLC fractionation and matrix-assisted laser desorption ionization-time of flight/time of 
flight (MALDI-TOF/TOF) were followed by a standard search of the National Center for 
Biotechnology Information and SwissProt databases using MASCOT. The ~150 kDa FLAG-
tagged MYOCD band from mouse bladder was similarly processed and analyzed.
Statistical analyses
Primary data were assessed for normality with a Shapiro-Wilk test or for equal variance (in 
case of one- or two-way ANOVA) and all datasets displayed normal distributions and 
variances. Accordingly, we used parametric paired t-test for comparisons between 
experimental and control conditions or one- and two-way ANOVA for multiple group 
comparisons. All data analysis was performed in GraphPad Prism 7. Results are expressed 
as mean ± standard deviation. A value of p<0.05 was considered statistically significant. For 
Mendelian inheritance of different alleles we used a Chi-square test.
Results
In vivo Myocardin Protein Expression and Binding Activity
There are at least four MYOCD isoforms with predicted molecular weights of 106 kDa (v1, 
983 amino acids), 101 kDa (v2, 935 amino acids), 97 kDa (v3, 904 amino acids), and 92 
kDa (v4, 856 amino acid).26, 27 Most commercial antibodies report endogenous MYOCD 
protein of ~100 kDa, consistent with the predicted molecular weights of each isoform. 
However, upon knockdown of Myocd mRNA there was no corresponding change in a 
widely assumed MYOCD protein band in A7r5 SMC, mouse and rat aorta and bladder, 
mouse aortic SMC, and human coronary artery SMC (Figure IB in the online-only Data 
Supplement and data not shown). Similar results were found using a different siRNA to 
Myocd in MASMC (Figure IC in the online-only Data Supplement). Mass spectrometry of 
the excised 100 kDa bands from rat aorta and bladder as well as the A7r5 SMC line revealed 
no evidence of MYOCD peptides (Table II in the online-only Data Supplement). Thus, while 
many commercial antibodies are able to reveal ectopic MYOCD expression (not shown), 
there is question as to the accuracy of detecting the endogenous MYOCD protein.
Accordingly, 3-component CRISPR11 was used to target the last coding exon of Myocd with 
either 3xFLAG or 3xHA epitope tags (Figure IIA in the online-only Data Supplement). 
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Correct targeting was validated by Sanger sequencing in 3xFLAG (4/35) and 3xHA (1/6) 
founders with no predicted off-targeting in linkage disequilibrium with the on-target site; 
sequence analysis of the top nine predicted distal off-target sites showed no mutations, 
consistent with the high specificity of the sgRNA (data not shown). The Myocd3xFLAG allele 
was bred through the germline and sibling-matings revealed an expected Mendelian ratio 
(Figure IID in the online-only Data Supplement). Western blotting supported biallelic 
expression of the Myocd gene (Figure 1A). The estimated molecular weight of FLAG-
tagged MYOCD was ~150 kDa, a size considerably larger than that reported in the 
literature; Myocd3xHA mice showed a similar sized band (Figure 1B). An independently 
generated Myocdmyc-HA mouse also revealed MYOCD to have a molecular mass of ~150 
kDa (Figure IIIA in the online-only Data Supplement). Adult tissue profiling showed highest 
expression of MYOCD in bladder and uterus with moderate levels in aorta; surprisingly 
lower levels of MYOCD protein were consistently seen in the adult heart (Figure 1C and 
Figure IIIB in the online-only Data Supplement). Importantly, mass spectrometry analysis of 
the 150 kDa band revealed small quantities of MYOCD protein (Table III in the online-only 
Data Supplement). ChIP-qPCR of Myocd3xFLAG aortic tissue showed significant enrichment 
of SRF-binding CArG sequences around several known targets of the SRF-MYOCD 
transcriptional switch (Figure 1D). Despite repeated efforts under numerous experimental 
conditions, no consistent MYOCD signal was obtained on tissue sections with an array of 
antibodies to FLAG (data not shown). These in vivo findings reveal a higher molecular 
weight of MYOCD than previously reported and define, for the first time, reliable detection 
of endogenous MYOCD protein expression and binding activity in adult mouse tissues.
In vitro Myocardin Protein Expression
The mTmG reporter mouse28 was crossed with the Myh11CreERT2 mouse29 to indelibly 
mark VSMC of the aortic wall with GFP. Most aortic cells from passage numbers 1–4 are 
GFP+; however, beginning at passage number five a notable decrease in GFP+ VSMC was 
seen (Figure IV in the online-only Data Supplement). Thus, in vitro studies were restricted 
to cultures of mouse VSMC at passage 1–3. Homozygous Myocd3xFLAG VSMC exhibited 
similar mRNA levels of SRF/MYOCD target genes as in wild type VSMC, suggesting the 
FLAG epitope tag did not adversely affect MYOCD activity (Figure VA in the online-only 
Data Supplement). Western blotting of passage two VSMC showed MYOCD protein 
comparable in size to that seen in tissues, indicating the molecular weight of MYOCD did 
not change appreciably upon culture (Figure VB in the online-only Data Supplement). 
Immunofluorescence microscopy disclosed nuclear-localized MYOCD in cultured VSMC 
(Figure 2A). Knockdown of Myocd mRNA (Figure 2B) resulted in reduced VSMC FLAG-
tagged MYOCD protein expression (Figure 2C and Figure VB-VC in the online-only Data 
Supplement); we estimate a reduction of at least 10-fold over si-control treated VSMC 
(Figure 2D). Collectively, these results authenticate a new mouse model for accurate 
detection of MYOCD protein in both adult tissues and cultured VSMC.
Discussion
We introduce new Myocardin mouse models wherein epitope tags (3xFLAG and 3xHA) 
were used to independently target the last coding exon of the Myocd locus. The motivation 
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for generating these mice stems from our long-standing difficulty in assessing endogenous 
levels of MYOCD protein expression in vivo or in vitro in mouse, human, and rat.30 The 
initial characterization of the epitope tagged mice reported here reveals several notable 
findings. First, the two-fold increase in MYOCD protein expression of homozygous versus 
heterozygous Myocd3xFLAG mice indicates biallelic gene transcription. Second, multiple 
epitope tags demonstrate the molecular weight of the endogenous MYOCD protein to be 
much higher (~150 kDa) than formerly reported. Indeed, with rare exception,31 the 
molecular weight of MYOCD protein, when reported, has been between 95–105 kDa. We 
show in data from two independent laboratories, using distinct reagents and cell types, that a 
putative MYOCD protein of ~100 kDa does not change with siRNA knockdown of Myocd 
mRNA. We therefore caution investigators using commercial antibodies to MYOCD and 
urge rigorous analysis to authenticate the specificity of bands so as to avoid further 
confusion in the field. The higher molecular weight of MYOCD over its predicted size of 
~100 kDa likely reflects a number of post-translational modifications shown previously to 
occur in MYOCD, at least in cultured model systems.30, 32 Precision CRISPR editing of key 
amino acids undergoing post-translational modification in the Myocd3xFLAG mouse may 
reveal more nuanced phenotypes than those reported in conditional Myocd knockouts of the 
heart and vessel wall.33, 34
Lower molecular weight bands were seen with FLAG antibodies, particularly in aorta, 
bladder, and uterus (Figure 1 and Supplemental Figures III and V). The identity of these 
bands is unknown at this time, but they could represent different MYOCD isoforms, 
differential post-translational modifications of a specific MYOCD isoform, or proteolytic 
cleavage products of MYOCD. The targeting of the C-terminus of MYOCD with epitope 
tags, as reported here, should allow for the detection and functional assessment, via 
precision CRISPR editing, of all previously described MYOCD isoforms.26, 27
Another noteworthy result was the low-level MYOCD protein in adult heart. This finding 
was seen in every experiment conducted and cannot be attributed to lower mRNA levels 
since we originally reported Myocd mRNA to be equivalent in heart and aorta (13), a finding 
we have repeated here (Supplemental Figure VI). The lower levels of MYOCD protein in 
adult heart as compared to bladder and aorta could reflect a known mechanism of 
microRNA-mediated repression during cardiac development. Such repression was shown to 
promote cardiomyocyte maturation while repressing the VSMC gene program.35, 36 
Interestingly, Myocd mRNA is elevated in heart failure,37 a condition characterized by the 
re-emergence of the fetal heart gene program, which includes an array of VSMC genes. 
Thus, it appears that levels of MYOCD protein are under exquisite control in the normal 
adult heart for optimal cardiac function.
The use of a FLAG antibody in ChIP-qPCR studies provides proof-of-principle data 
supporting ChIP-seq studies in the vessel wall under normal or stress-induced conditions. In 
this context, a growing number of SRF-independent target genes of MYOCD have been 
reported.30 The ability to generate mice in which each Myocd allele carries either a 3xFLAG 
or 3xHA tag offers a rigorous approach to define novel DNA binding sequences and the 
corresponding DNA-binding transcription factors associated with MYOCD. The mice 
reported here will also be useful for the discovery of new MYOCD binding proteins or 
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RNAs, especially the class of long non-coding RNA. These and other studies will further 
illuminate MYOCD biology, thus providing a more integrative understanding of how this 
cofactor functions under normal and pathological conditions.
In contrast to adult tissues, nuclear-localized MYOCD was observed consistently in cultured 
VSMC as demonstrated in siRNA knockdown studies. Previous mouse studies showed 
FLAG-tagged protein expression in tissue sections38 suggesting there may be some steric 
hindrance in detecting the MYOCD protein in vivo. It is possible the epitope is masked 
through interactions of MYOCD with other molecules in the cell.30, 32 On the other hand, 
we have observed consistent staining in adult mouse tissues carrying an inducible HA-
tagged Myocd transgene (unpublished), and preliminary staining of aorta carrying the 
Myocd3xHA tag suggests that it could be a more discriminating epitope tag than 3xFLAG for 
immunostaining, though this will require further analysis. Importantly, genetically marked 
VSMC progressively decrease from culture indicating the need for careful experimental 
design and circumspect conclusions drawn from in vitro primary VSMC experiments.
The CRISPR revolution has expedited the generation of new mouse models.11 We anticipate 
similarly tagged mice, as those reported here, will be developed for rigorous protein 
analyses and accelerated discoveries in vascular biology.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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3cCRISPR Three-component CRISPR
CRISPR Clustered regularly interspaced short palindromic repeats
Cas9 CRISPR-associated protein 9
sgRNA Single guide RNA
HDR Homology directed repair
MASMC Mouse aortic smooth muscle cell(s)
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RFLP Restriction fragment length polymorphism
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Highlights
• Non-discriminating antibodies have hampered the reliable detection of 
Myocardin protein.
• CRISPR-Cas9 genome editing was used to knock-in epitope tags at the C-
terminal end of the Myocardin locus.
• The molecular mass of Myocardin protein is ~150 kDa, a size much larger 
than that reported in the vast literature.
• Epitope tagging of Myocardin allows for facile detection of nuclear 
Myocardin in cultured cells as well as associated DNA binding as revealed 
with ChIP-qPCR.
• Epitope tagging of genes with CRISPR affords an unambiguous assessment 
of protein expression, localization, and associated interactions in the cell.
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Figure 1. In vivo MYOCD protein expression and binding activity.
(A) Western blot of MYOCD3xFLAG in wildtype (+/+) versus heterozygous and homozygous 
FLAG(FL)-tagged MYOCD in indicated male mouse tissues. HEK-293 cells untransfected 
(−) or transfected (+) with 3xFLAG-tagged v1 isoform of MYOCD served as a control. (B) 
Parallel Western blots of MYOCD3xFLAG or MYOCD3xHA tagged tissues. (C) Tissue profile 
of MYOCD3xFLAG expression in indicated female tissues. Similar results were seen in 
several independent experiments over the course of two years. (D) In vivo ChIP-qPCR in 
homozygous Myocd3xFLAG aortae for the indicated target genes using FLAG or IgG control. 
Data are expressed as fold enrichment of FLAG sequence over IgG control. All results were 
confirmed in at least one independent experiment. Data passed test for normality and paired 
t-test showed significantly increased enrichment of PCR products with the anti-FLAG 
antibody, p < 0.01.
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Figure 2. In vitro MYOCD protein expression.
(A) Immunofluorescence microscopy of MYOCD3xFLAG in low-passaged mouse aortic 
SMC (MASMC). Note abundant nuclear staining in Myocd3xFLAG MASMC versus wild-
type controls. (B) Quantitative RT-PCR following siRNA knockdown of Myocd mRNA in 
cultured MASMC. (C) Immunofluor-escence microscopy of MYOCD3xFLAG in MYH11 
positive MASMC treated with si scrambled control (siCtrl, top) or siMyocd (bottom). Scale 
bar here and in panel A is 10 μm. (D) Quantitative analysis (by two independent, blinded 
investigators) of number of MYOCD-FLAG positive cells co-staining for MYH11. See also 
Figure VC in the online-only Data Supplement.
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